Truist Financial Cuts Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $28.00
Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price target trimmed by Truist Financial from $31.00 to $28.00 in a report issued on Thursday,Benzinga reports. The firm currently has a buy rating on the medical device company’s stock. TNDM has been the subject of several other reports. William Blair started coverage on shares of […]
27 Sep 02:01 · The Cerbat Gem